Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levelsMONTGOMERY, Stuart A; ALTAMURA, A. Carlo; KATILA, Heikki et al.International clinical psychopharmacology. 2014, Vol 29, Num 2, pp 93-105, issn 0268-1315, 13 p.Article

Self-Reported Sedation Profile of Immediate-Release Quetiapine Fumarate Compared With Extended-Release Quetiapine Fumarate During Dose Initiation : A Randomized, Double-Blind, Crossover Study in Healthy Adult SubjectsDATTO, Catherine; BERGGREN, Lovisa; PATEL, Jitendra B et al.Clinical therapeutics. 2009, Vol 31, Num 3, pp 492-502, issn 0149-2918, 11 p.Article

Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder^tMEZHEBOVSKY, Irina; MÄGI, Kairi; SHE, Fahua et al.International journal of geriatric psychiatry. 2013, Vol 28, Num 6, pp 615-625, issn 0885-6230, 11 p.Article

Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled studyMERIDETH, Charles; CUTLER, Andrew J; FAHUA SHE et al.International clinical psychopharmacology. 2012, Vol 27, Num 1, pp 40-54, issn 0268-1315, 15 p.Article

A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety DisorderKHAN, Arifulla; JOYCE, Mark; ATKINSON, Sarah et al.Journal of clinical psychopharmacology. 2011, Vol 31, Num 4, pp 418-428, issn 0271-0749, 11 p.Article

Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatmentBAUER, Michael; DEMYTTENAERE, Koen; EL-KHALILI, Nizar et al.International clinical psychopharmacology. 2014, Vol 29, Num 1, pp 16-25, issn 0268-1315, 10 p.Article

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of High-Dose Quetiapine in Patients With Persistent Symptoms of Schizophrenia or Schizoaffective DisorderHONER, William G; WILLIAM MACEWAN, G; GENDRON, Alain et al.The Journal of clinical psychiatry. 2012, Vol 73, Num 1, pp 13-20, issn 0160-6689, 8 p.Article

Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group studyDE DEYN, Peter Paul; ERIKSSON, Hans; SVENSSON, Hanna et al.International journal of geriatric psychiatry. 2012, Vol 27, Num 3, pp 296-304, issn 0885-6230, 9 p.Article

Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorderVIETA, Eduard; BAUER, Michael; MONTGOMERY, Stuart et al.Journal of affective disorders. 2013, Vol 150, Num 2, pp 639-643, issn 0165-0327, 5 p.Article

Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacyTHASE, Michael E; MONTGOMERY, Stuart; PAPAKOSTAS, George I et al.International clinical psychopharmacology. 2013, Vol 28, Num 3, pp 113-120, issn 0268-1315, 8 p.Article

A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorderBAUER, Michael; EL-KHALILI, Nizar; DATTO, Catherine et al.Journal of affective disorders. 2010, Vol 127, Num 1-3, pp 19-30, issn 0165-0327, 12 p.Article

Efficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorderMONTGOMERY, Stuart A; LOCKLEAR, Julie C; SVEDSÄTER, Henrik et al.International clinical psychopharmacology. 2014, Vol 29, Num 5, pp 252-262, issn 0268-1315, 11 p.Article

Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): Data from a randomized-withdrawal, placebo-controlled maintenance studySHEEHAN, David V; SVEDSÄTER, Henrik; LOCKLEAR, Julie C et al.Journal of affective disorders. 2013, Vol 151, Num 3, pp 906-913, issn 0165-0327, 8 p.Article

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized studyBORTNICK, Brian; EL-KHALILI, Nizar; BANOV, Michael et al.Journal of affective disorders. 2011, Vol 128, Num 1-2, pp 83-94, issn 0165-0327, 12 p.Article

Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trialKATZMAN, Martin A; BRAWMAN-MINTZER, Olga; REYES, Efren B et al.International clinical psychopharmacology. 2011, Vol 26, Num 1, pp 11-24, issn 0268-1315, 14 p.Article